HoxB13 mediates AR-V7 activity in prostate cancer

被引：14
|
作者：
Navarro, Hector I. [1 ]
Goldstein, Andrew S. [2 ,3 ,4 ,5 ]
机构：
[1] Univ Calif Los Angeles, Mol Biol Interdept Program, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Broad Stem Cell Res Ctr, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
来源：
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2018年 / 115卷 / 26期
关键词：
ANDROGEN RECEPTOR;
D O I：
10.1073/pnas.1808196115
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：6528 / 6529
页数：2
相关论文
共 50 条
  • [21] Synonymous Polymorphisms in HOXB13 as a Protective Factor for Prostate Cancer
    Albitar, Ferras
    Diep, Kevin
    Ma, Wanlong
    Albitar, Maher
    JOURNAL OF CANCER, 2015, 6 (05): : 409 - 411
  • [22] HOXB13, RFX6 and prostate cancer risk
    Mills, Ian G.
    NATURE GENETICS, 2014, 46 (02) : 94 - 95
  • [23] AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption
    Sobhani, Navid
    Neeli, Praveen Kumar
    D'Angelo, Alberto
    Pittacolo, Matteo
    Sirico, Marianna
    Galli, Ilaria Camilla
    Roviello, Giandomenico
    Nesi, Gabriella
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [24] Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
    Sun, Maxine
    Abdollah, Firas
    EUROPEAN UROLOGY, 2015, 68 (01) : 162 - 163
  • [25] Dissecting the mechanism of AR-v7 nuclear translocation in prostate cancer
    Kim, Seaho
    Jamalruddin, Mohd Azrin
    Portella, Luigi
    Giannakakou, Paraskevi
    CANCER RESEARCH, 2016, 76
  • [26] HOXB13 and other high penetrant genes for prostate cancer
    Pilie, Patrick G.
    Giri, Veda N.
    Cooney, Kathleen A.
    ASIAN JOURNAL OF ANDROLOGY, 2016, 18 (04) : 530 - 532
  • [27] Germline Mutations in HOXB13 and Prostate-Cancer Risk
    Ewing, Charles M.
    Ray, Anna M.
    Lange, Ethan M.
    Zuhlke, Kimberly A.
    Robbins, Christiane M.
    Tembe, Waibhav D.
    Wiley, Kathleen E.
    Isaacs, Sarah D.
    Johng, Dorhyun
    Wang, Yunfei
    Bizon, Chris
    Yan, Guifang
    Gielzak, Marta
    Partin, Alan W.
    Shanmugam, Vijayalakshmi
    Izatt, Tyler
    Sinari, Shripad
    Craig, David W.
    Zheng, S. Lilly
    Walsh, Patrick C.
    Montie, James E.
    Xu, Jianfeng
    Carpten, John D.
    Isaacs, William B.
    Cooney, Kathleen A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02): : 141 - 149
  • [28] HOXB13, RFX6 and prostate cancer risk
    Ian G Mills
    Nature Genetics, 2014, 46 : 94 - 95
  • [29] Evaluation of HOXB13 as a molecular marker of recurrent prostate cancer
    Jeong, Tae-O
    Oh, Kyung-Jin
    Nguyen Thi Xuan Nguyen
    Kim, Young-Rang
    Kim, Min Soo
    Lee, Sang Don
    Ryu, Soo Bang
    Jung, Chaeyong
    MOLECULAR MEDICINE REPORTS, 2012, 5 (04) : 901 - 904
  • [30] Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer
    Chen, Yonghong
    Dufour, Catherine R.
    Han, Lingwei
    Li, Ting
    Xia, Hui
    Giguere, Vincent
    MOLECULAR CANCER RESEARCH, 2023, 21 (10) : 1050 - 1063
12345